Compare · MEDP vs ONMD
MEDP vs ONMD
Side-by-side comparison of Medpace Holdings Inc. (MEDP) and OneMedNet Corp (ONMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MEDP and ONMD operate in Biotechnology: Commercial Physical & Biological Resarch (Health Care), so they compete in similar markets.
- MEDP is the larger of the two at $17.21B, about 607.8x ONMD ($28.3M).
- ONMD has been more active in the news (14 items in the past 4 weeks vs 13 for MEDP).
- MEDP has more recent analyst coverage (25 ratings vs 0 for ONMD).
- Company
- Medpace Holdings Inc.
- OneMedNet Corp
- Price
- $613.48-2.45%
- $4.73+1.50%
- Market cap
- $17.21B
- $28.3M
- 1M return
- -
- -28.46%
- 1Y return
- -
- -81.52%
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- 2021
- News (4w)
- 13
- 14
- Recent ratings
- 25
- 0
Medpace Holdings Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Latest MEDP
- SEC Form 4 filed by Medpace Holdings Inc.
- SEC Form 4 filed by Medpace Holdings Inc.
- Director Mccarthy Cornelius P. Iii converted options into 28 shares, increasing direct ownership by 0.23% to 12,303 units (SEC Form 4)
- Director Kraft Robert O. converted options into 32 shares, increasing direct ownership by 3% to 987 units (SEC Form 4)
- Director Carley Brian T converted options into 36 shares, increasing direct ownership by 0.13% to 27,861 units (SEC Form 4)
- President & CEO Troendle August J. sold $30,320,929 worth of shares (48,667 units at $623.03), decreasing direct ownership by 13% to 338,225 units (SEC Form 4)
- UBS resumed coverage on Medpace with a new price target
- President & CEO Troendle August J. sold $1,589,941 worth of shares (2,564 units at $620.10), decreasing direct ownership by 0.66% to 386,892 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by Medpace Holdings Inc.
- President & CEO Troendle August J. sold $27,403,895 worth of shares (43,916 units at $624.01), decreasing direct ownership by 10% to 389,456 units (SEC Form 4)
Latest ONMD
- OneMedNet Adds Leading Hospital System Provider Network, Expanding By Up to 12 Hospitals
- SEC Form 8-K filed by OneMedNet Corp
- SEC Form 4 filed by OneMedNet Corp
- SEC Form 4 filed by OneMedNet Corp
- SEC Form 4 filed by OneMedNet Corp
- SEC Form 4 filed by OneMedNet Corp
- OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution
- SEC Form 424B3 filed by OneMedNet Corp
- SEC Form 424B3 filed by OneMedNet Corp
- OneMedNet Corp filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits